AiCure, a NYC-based AI driven healthcare platform, raised a total of US $ 24.5m in Series C funding.
The round was led by Palisades Growth Capital (PGC) with participation from Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners and SpringRock Ventures, Baird Capital, New Leaf Venture Partners, Pritzker Group, Biomatics Capital, Tribeca Venture Partners and Silicon Valley Bank (SVB).
The company intends to use the funds to accelerate business activities.
Founded in 2010 and led by Adam Hanina, CEO, AiCure uses artificial intelligence to see, hear and understand how people respond to treatment through clinical trials and patient care. Clinically proven to measure and modify patient behavior, the company’s technologies keep patients engaged and optimized for treatment, as well as to evaluate the effectiveness of treatment.
The company has more than 100 registered patents and works with global clients in more than 25 countries.